2m 2m 2m 2m 2m 2m 2m
INCANNEX HEAL (IXHL)
NASDAQ
$2.95+$0.02 (+0.68%)
Price as of Aug 03, 2026 7:59 PM EDT- $35.2MMarket Cap
- -74.58%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INCANNEX HEAL (IXHL)
$2.95+$0.02 (+0.68%)
IXHL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.93 | ||
Change | +$0.010 (+0.34%) | ||
Open | $2.94 | ||
High | $3.12 | ||
Low | $2.91 | ||
Previous Close | $2.94 | ||
Volume | 157,464 | ||
30-Day Average Volume | 177,306 | ||
1-Week Change | -0.34% | ||
1-Month Change | -21.81% | ||
1-Year Change | -74.58% | ||
3-Year Change | -94.59% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.0M | ||
Total Assets | $80.3M | ||
Market Cap | $35.2M | ||
Enterprise Value | -$39.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.9M | ||
Free Cash Flow | -$2.5M | ||
EBIT | -$3.9M | ||
EBITDA | -$3.8M | ||
Net Working Capital | $78.2M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | 10 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/27/2026 | ||